Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track SPRC with free AI briefings, catalyst countdowns, and dilution alerts.

SPRC · SciSparc Ltd.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$4.4M Cash on Hand
9.1mo Cash Runway
Follow SPRC by email Get an email when SPRC reports key news in an SEC filing, pushes back a promised milestone, files for a stock offering, lands on the Downside Radar or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about SPRC, unsubscribe in one click. Privacy

📣 What SPRC Says Is Next

Quoted word for word from the company's press releases filed with the SEC. Timing is the company's own guidance, not a BioRadar estimate.

📄 Latest SEC Filings in Plain English

Each summary is written by AI from the filing itself, and one that names a number or a name the filing does not contain is not shown. Quarterly and annual reports are listed by period. Read the filing before acting on it.

💰 Cash Runway & Dilution Risk

SPRC holds $4.4M in cash and short-term investments and burns about $1.5M/quarter from operations, an estimated runway of 9.1 months at that rate (BioRadar estimate, not company guidance).

Dilution pressure: 30 · Moderate

Recent financing filings on SEC EDGAR:

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when SPRC files for a raise →

👥 Who Owns SPRC

Insiders 100% Institutions (8 holders) 0% Public and other holders 0%
HolderTypeShares% of sharesAs of
SciSparc Ltd.
10% owner
Insider 490,751 134.29% 2025-10-20
Oz Adler
CEO and CFO
Insider 11,058 3.03% 2026-03-18
Amitay Weiss
Director
Insider 11,058 3.03% 2026-03-18
Itschak Shrem
Director
Insider 10,596 2.90% 2026-06-01
Adi Zuloff-Shani
Chief Technology Officer
Insider 5,528 1.51% 2026-03-18
Lior Vider
Director
Insider 3,649 1.00% 2026-03-18
Amnon Ben Shay
Director
Insider 3,649 1.00% 2026-03-18
Moshe Revach
Director
Insider 3,649 1.00% 2026-03-18
Liat Sidi
Director
Insider 3,649 1.00% 2026-03-18
Alon Dayan
Director
Insider 3,649 1.00% 2026-03-18

Share count 365,444 (latest 10-Q/10-K). Insiders: each officer's, director's and 10% owner's latest Form 3, 4 or 5, direct and indirect shares; options are not counted. 5%+ holders: latest Schedule 13D or 13G of each holder above 5%. Institutions: the total held by all 13F filers (Yahoo Finance); the table lists the largest. Sources have different dates, so the split is approximate. Source: SEC EDGAR.

Get the full SPRC picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for SPRC and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.